We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ZVRA market cap is 262.42M. The company's latest EPS is USD -1.1002 and P/E is -5.70.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2.88M | 8.47M | 2.9M | 13.22M | 3.43M |
| Operating Income | -12.92M | -6.65M | -15.36M | -14.67M | -20.49M |
| Net Income | -11.77M | -5.08M | -14.05M | -15.15M | -16.62M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 12.84M | 13.29M | 28.65M | 10.46M | 27.46M |
| Operating Income | -20.34M | -5.61M | 7.73M | -42.51M | -49.6M |
| Net Income | -24.52M | -12.76M | -62.9M | -41.54M | -46.05M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 106.6M | 105.52M | 138.98M | 172.33M | 151.28M |
| Total Liabilities | 35.19M | 37.02M | 71.51M | 110.46M | 102.47M |
| Total Equity | 71.4M | 68.5M | 67.47M | 61.86M | 48.82M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 10.51M | 11.21M | 132.94M | 115.53M | 172.33M |
| Total Liabilities | 84.96M | 77.62M | 5.82M | 29.72M | 110.46M |
| Total Equity | -74.46M | -66.41M | 127.12M | 85.81M | 61.86M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.05M | -12.75M | -17.38M | -33.54M | -16.17M |
| Investing | -17.56M | 16.48M | -27.98M | -17.39M | 14.79M |
| Financing | -3.75M | -2.8M | 23.46M | 28.46M | 1.22M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -23.74M | -1.94M | 10.44M | -18.72M | -33.54M |
| Investing | 3.23M | -33k | -15.52M | -36.72M | -17.39M |
| Financing | 4.94M | 2.74M | 113.11M | 8.35M | 28.46M |
| Market Cap | 262.42M |
| Price to Earnings Ratio | -5.70 |
| Price to Sales Ratio | 9.56 |
| Price to Cash Ratio | 6.1 |
| Price to Book Ratio | 4.24 |
| Dividend Yield | - |
| Shares Outstanding | 41.85M |
| Average Volume (1 week) | 407.93k |
| Average Volume (1 Month) | 516.61k |
| 52 Week Change | 28.22% |
| 52 Week High | 7.28 |
| 52 Week Low | 3.89 |
| Spread (Intraday) | 1.54 (22.68%) |
| Company Name | Zevra Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.kempharm.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
